(Q50943815)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Telomerase-specific oncolytic adenovirus: antitumor effects on radiation-resistant head and neck squamous cell carcinoma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

1 reference

head and neck squamous cell carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Daisuke Sano

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Hideaki Takahashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Chihiro Horii

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Masahiro Takahashi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Goshi Nishimura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Takahide Taguchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Norio Kondo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Atsuko Sakakibara

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yasuo Urata

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

411-418

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

cites work

Global cancer statistics

1 reference

Advances in radiotherapy for head and neck cancer

21 January 2018

1 reference

The expanding role of systemic therapy in head and neck cancer

21 January 2018

1 reference

How telomeres solve the end-protection problem

21 January 2018

1 reference

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas

21 January 2018

1 reference

Radiation enhances suicide gene therapy in radioresistant laryngeal squamous cell carcinoma via activation of a tumor-specific promoter

21 January 2018

1 reference

Telomerase-specific replication-selective virotherapy for human cancer

21 January 2018

1 reference

Establishment of biological and pharmacokinetic assays of telomerase-specific replication-selective adenovirus

21 January 2018

1 reference

Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma

21 January 2018

1 reference

Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines

21 January 2018

1 reference

Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery

21 January 2018

1 reference

Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination

21 January 2018

1 reference

Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer

21 January 2018

1 reference

Short tandem repeat profiling provides an international reference standard for human cell lines

21 January 2018

1 reference

Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro.

21 January 2018

1 reference

Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2.

21 January 2018

1 reference

Xenograft models of head and neck cancers

21 January 2018

1 reference

The mammalian Mre11-Rad50-nbs1 protein complex: integration of functions in the cellular DNA-damage response

21 January 2018

1 reference

DNA damage-dependent nuclear dynamics of the Mre11 complex

21 January 2018

1 reference

The Mre11 complex is required for ATM activation and the G2/M checkpoint

21 January 2018

1 reference

Adenovirus E4 34k and E4 11k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase

21 January 2018

1 reference

Telomere dysfunction is related to the intrinsic radio-resistance of human oral cancer cells

21 January 2018

1 reference

Shortened telomeres join to DNA breaks interfering with their correct repair.

21 January 2018

1 reference

The hTERT promoter enhances the antitumor activity of an oncolytic adenovirus under a hypoxic microenvironment

21 January 2018

1 reference

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

21 January 2018

1 reference

TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.

21 January 2018

1 reference

Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer

21 January 2018

1 reference

A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors

21 January 2018

1 reference

Use of replicating oncolytic adenoviruses in combination therapy for cancer

21 January 2018

1 reference

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

Trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States, 1973-1987

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HED.23309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23728900%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference